Boothbay Fund Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-66,276
| Closed | -$272K | – | 2543 |
|
|
2022
Q1 | $272K | Sell |
66,276
-208,749
| -76% | -$857K | 0.01% | 1318 |
|
|
2021
Q4 | $982K | Buy |
275,025
+101,315
| +58% | +$362K | 0.02% | 643 |
|
|
2021
Q3 | $632K | Buy |
173,710
+93,288
| +116% | +$339K | 0.02% | 801 |
|
|
2021
Q2 | $351K | Buy |
80,422
+45,983
| +134% | +$201K | 0.01% | 1044 |
|
|
2021
Q1 | $142K | Sell |
34,439
-23,475
| -41% | -$96.8K | 0.01% | 1200 |
|
|
2020
Q4 | $231K | Buy |
57,914
+36,168
| +166% | +$144K | 0.01% | 890 |
|
|
2020
Q3 | $59K | Buy |
21,746
+10,504
| +93% | +$28.5K | ﹤0.01% | 870 |
|
|
2020
Q2 | $31K | Sell |
11,242
-26,756
| -70% | -$73.8K | ﹤0.01% | 804 |
|
|
2020
Q1 | $90K | Buy |
+37,998
| New | +$90K | 0.01% | 640 |
|
|
2019
Q4 | – | Sell |
-557,477
| Closed | -$1.87M | – | 975 |
|
|
2019
Q3 | $1.87M | Buy |
557,477
+157,415
| +39% | +$527K | 0.17% | 133 |
|
|
2019
Q2 | $1.32M | Buy |
400,062
+240,280
| +150% | +$790K | 0.12% | 162 |
|
|
2019
Q1 | $484K | Buy |
+159,782
| New | +$484K | 0.05% | 312 |
|
|
2018
Q3 | – | Sell |
-15,676
| Closed | -$40K | – | 877 |
|
|
2018
Q2 | $40K | Buy |
+15,676
| New | +$40K | ﹤0.01% | 587 |
|
|
2018
Q1 | – | Sell |
-12,110
| Closed | -$24K | – | 827 |
|
|
2017
Q4 | $24K | Buy |
+12,110
| New | +$24K | ﹤0.01% | 606 |
|